Latest news with #MitraClip
Hindustan Times
4 days ago
- Health
- Hindustan Times
Cardiologists says he wishes more people knew how to 'avoid open heart surgery': No chest cutting, bypass machine needed
Dr Dmitry Yaranov, a cardiologist known as 'Heart Transplant Doc' on Instagram, took to the platform on August 9 to share a post in which he said, 'Being a cardiologist for years, I wish more people knew they could avoid open-heart surgery.' In his post, the doctor explained how mitral and tricuspid valves are crucial in maintaining blood flow in the right direction. Also read | Minimally invasive cardiac surgery: Heart risks for your parents, benefits, lifestyle changes, recovery secrets The cardiologist explained how minimally invasive procedures like MitraClip and TriClip offer promising solutions for patients with leaky heart valves. (Representative image) He said, 'We used to crack open the chest to fix a leaky heart valve. Now? We clip it — through a vein. Let's talk mitral and tricuspid valves — the heart's inlet valves, constantly working to keep blood flowing in the right direction. But when they leak — called regurgitation — blood flows backward, and the heart starts to fail.' What are MitraClip and TriClip? When these valves leak, it can lead to serious complications, but fortunately, advancements in medical technology have introduced minimally invasive procedures to address these issues, Dr Yaranov highlighted. He said, 'Old-school fix? Open-heart surgery. Not everyone could handle it. Today? We've flipped the script. With devices like MitraClip (for mitral) and TriClip (for tricuspid), we can fix the valve without surgery.' MitraClip is a device used to treat mitral regurgitation, a condition where the mitral valve leaks, allowing blood to flow backward. The MitraClip is inserted through a vein in the leg and clips the valve's leaflets together to reduce leakage. TriClip, a similar device designed for the tricuspid valve, also clips the leaflets together to minimise regurgitation. The TriClip is specifically made for the tricuspid valve and has shown promising results in reducing symptoms and hospitalisations for heart failure. 'Small clip, big impact' Explaining these, Dr Yaranov said, 'Just a catheter through a vein in the leg. No chest cutting. No bypass machine. Just a tiny clip, placed right on the valve. It brings the leaflets together, reduces the leak, and the patient usually goes home the next day. Mitral regurgitation is the most common valve disease in the US. And tricuspid used to be ignored — but not anymore. We're now treating patients who were once told 'there's nothing we can do'. And they're walking out stronger — without ever seeing an OR (operating room). This isn't the future of valve care. It's happening now. Small clip. Big impact.' What is an open heart surgery? According to The National Heart, Lung, and Blood Institute (NHLBI), open heart surgery is a procedure where surgeons operate on the heart after making a large incision in the chest to access the heart and surrounding structures. It's typically used to address severe heart conditions like coronary artery disease, faulty valves, or congenital defects. During the surgery, a heart-lung bypass machine often maintains circulation while the heart is stopped to allow for repair. Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
Yahoo
23-06-2025
- Health
- Yahoo
Dr. Juan Pablo Umaña Joins the Miller School and UHealth as Chief of Cardiothoracic Surgery
MIAMI, June 23, 2025 /PRNewswire/ -- The Miller School of Medicine and UHealth – University of Miami Health System welcome Juan Pablo Umaña, M.D., an internationally recognized leader in cardiovascular surgery, as professor and Chief of Cardiothoracic Surgery, effective June 2. Known for his pioneering contributions to aortic and mitral valve repair, Dr. Umaña brings not only surgical excellence but also a deep commitment to patient-centered care. Dr. Umaña established the most extensive aortic and mitral valve repair program in Latin America and founded the Latin-American Cardiovascular Surgery Conference. His arrival at the University of Miami signals an exciting new chapter for the institution's cardiovascular program. "The University of Miami offers the ideal platform to pursue a lifelong vision — to build a world-class cardiovascular program focused not just on innovation, but on patients," Dr. Umaña said. "While UM is already recognized as a center of excellence for mitral valve surgery, there's an extraordinary opportunity to grow an aortic surgery program and create an integrated, collaborative hub for cardiovascular care." "We are pleased to welcome someone of Dr. Umaña's caliber to the UHealth team," added Dipen J. Parekh, M.D., chief executive officer of UHealth and founding director of the Desai Sethi Urology Institute. "His expertise, commitment to innovation, and focus on training will elevate every aspect of our cardiovascular surgery program." A Life of Learning and Leadership Dr. Umaña earned his medical degree from the University of El Rosario in Bogotá, Colombia. He deepened his expertise through social service and research in England before completing advanced surgical training at Columbia University in New York City and Stanford University in California. His leadership at Fundación Cardioinfantil – Instituto de Cardiología transformed it into one of Latin America's premier cardiovascular centers. Most recently, he chaired the Division of Thoracic and Cardiovascular Surgery at the Cleveland Clinic Florida. With more than 150 scientific publications and presentations, Dr. Umaña is a leading voice in global cardiovascular research. He was the co-inventor of the MitraClip, the first transcatheter mitral valve repair device used in clinical practice today, which allows the mitral valve to be repaired without opening the chest. Read full press release. Link to Dr. Umaña's professional headshot. View original content: SOURCE University of Miami Health System
Time of India
13-06-2025
- Health
- Time of India
Can AI-driven tech make heart diseases preventable?
New Delhi: As cardiovascular disease continues to top the global chart of chronic illnesses, technology is emerging as the most powerful ally in combating it. In a conversation with Dr. Ethan Korngold , Divisional Vice President Medical Affairs and Chief Medical Officer for Abbott's vascular business, we explore how artificial intelligence (AI), minimally invasive devices , and digital health are reshaping cardiovascular care—from high-tech cath labs to underserved rural India. The Rise of Smart Heart Care 'Heart care is moving fast—and we're moving with it,' says Dr. Korngold. Abbott's Ultreon 2.0, an AI-enhanced imaging platform that uses Optical Coherence Tomography (OCT) to offer 20 times magnification over standard angiograms. This ultra-HD view lets cardiologists measure artery size, assess blockages, and determine plaque composition—rapidly and accurately. 'With Ultreon, decision-making in the cath lab is more precise and faster,' explains Dr. Korngold. 'It's like shifting from blurry black-and-white to crystal-clear, color-rich imaging. The AI processes data in real-time, helping doctors place stents with pinpoint precision and improve patient outcomes.' The promise of AI in cardiovascular care isn't limited to imaging. Abbott is already piloting Virtual Flow Reserve (VFR), a cutting-edge technology that will use AI to estimate the severity of blockages by analyzing blood flow dynamics—non-invasively. This could significantly reduce unnecessary procedures by helping physicians target the most critical lesions. Abbott's MitraClip has revolutionized how leaky heart valves are treated. Delivered via a vein rather than through open-heart surgery, MitraClip is a lifeline for patients deemed too high-risk for traditional operations. 'It restores quality of life with minimal recovery time,' Dr. Korngold notes. Amplatzer Piccolo Occluder—a device no larger than a pea that helps close a life-threatening heart defect (patent ductus arteriosus) in premature infants weighing as little as 700 grams. 'This is one of the tiniest devices with one of the biggest impacts,' he says. Tackling Complex Heart Cases Dr. Korngold sees a future where AI can predict blockages before they form, allowing doctors to prevent heart attacks before patients feel a single symptom. Abbott's XIENCE Sierra , part of its flagship drug-eluting stent family, is built for complex percutaneous coronary intervention (PCI) procedures. Its adaptive design and unique fluoropolymer coating make it easier to navigate tortuous arteries and reduce risks of clotting and restenosis. 'XIENCE Sierra gives doctors the flexibility and control they need in difficult cases, with long-term performance,' explains Dr. Korngold. For heavily calcified arteries, Abbott's acquisition of Cardiovascular Systems Inc. (CSI) brought in the Diamondback 360 Orbital Atherectomy System. Using a diamond-coated crown, this system gently sands away hardened plaque, making vessels more compliant and easier to treat with stents or balloons. 'It's a key tool in our arsenal for treating high-risk patients who need precision and safety,' he adds. Reaching Rural India One of the most exciting opportunities lies beyond hospitals. In remote and underserved areas, virtual care is bridging the healthcare divide. The smart implantable devices—pacemakers and heart monitors—can now transmit data wirelessly to physicians, enabling remote monitoring and treatment adjustments. 'Patients no longer need to travel miles for routine follow-ups,' says Dr. Korngold. 'We're building scalable, connected care ecosystems that empower both patients and providers—especially in resource-constrained settings.' AI and digital health are set to redefine every stage of cardiovascular care—from early risk detection to remote patient monitoring and precision-guided interventions.
Malaysian Reserve
04-06-2025
- Business
- Malaysian Reserve
MemorialCare Heart & Vascular Institute Completes First Successful TriClip Procedure for Tricuspid Valve Repair
LONG BEACH, Calif., June 4, 2025 /PRNewswire/ — The cardiology team at the MemorialCare Heart & Vascular Institute at Long Beach Medical Center, led by Chief of Cardiology David Shavelle, M.D., performed Long Beach Medical Center's first transcatheter tricuspid valve replacement procedure using a new, innovative treatment option – the transcatheter edge-to edge repair (TEER) TriClip G4 System in September of 2024. The FDA-approved TriClip is a small clipping device designed to clip two or more of the leaflets of the tricuspid, offering a minimally invasive treatment option to patients who have tricuspid regurgitation (TR) – a condition where the tricuspid valve does not close completely when the right ventricle contracts. This device – implanted via a catheter inserted in the vein of the leg – helps reduce tricuspid regurgitation and promotes an immediate improvement in blood flow and allows patients to benefit from a less traumatic procedure and a faster recovery. This advanced technology marks a new era for treating tricuspid valve disease since prior to its introduction, patients could only receive a device better suited for the mitral valve (MitraClip® device). The TriClip device was specifically made for the tricuspid valve. In a large clinical trial, the device was shown to reduce symptoms and hospitalization for heart failure for patients at high-risk for open-heart surgery. 'This new procedure represents a significant advancement in our ability to treat high-risk patients with tricuspid valve heart disease,' says Dr. Shavelle, who led the landmark procedure. 'Historically there wasn't much we could do for those who still had symptoms after tricuspid regurgitation treatment and who were at high-risk for open heart surgery. This device gives patients access to improved quality of life.' This procedure was performed by a highly skilled, diverse team of cardiologists, cardiac surgeons, cardiac anesthesiologists and advanced imaging specialists from the MemorialCare Heart & Vascular Institute at Long Beach Medical Center. Implantation of the TriClip with the TriClip G4 System is as effective as open-heart surgery, helping patients return to their daily lives in one to two days. 'The patient recovered in the hospital for about two days, and he was able to return to his daily life the following day,' says Dr. Shavelle. 'It's amazing to see the positive impact this device has on our patients, allowing them to return to their daily lives with improved heart function and overall well-being.' The patient who received this procedure, Anthony Williams, reported being fatigued constantly with excessive swelling of the legs (edema) before the procedure. Today, he is more energetic than ever and ready to take on each day. MemorialCare Heart & Vascular Institute at Long Beach Medical Center is the first institute in the region to use this device and continues to lead in cardiovascular innovations, bringing patients with the latest technology advancements. As one of the most high performing hospitals according to U.S. News, MemorialCare Long Beach Medical Center is a six-time five-star recipient recognized for its excellence in cardiac care by Healthgrades, and has recently received the American Heart Association's Get With The Guidelines® Heart Failure Gold Plus Quality Achievement Award, as well as the American Heart Association/American Stroke Association's Get With The Guidelines® Stroke Gold Plus Quality Achievement Award. With these achievements and offering a comprehensive range of services for patients with cardiac disorders, including rehabilitation programs, Long Beach Medical Center is a community hospital dedicated in providing expert and compassionate care on par with those found in academic settings. About MemorialCare Long Beach Medical Center: MemorialCare Long Beach Medical Center is a member of MemorialCare, a not-for-profit, integrated healthcare system. Long Beach Medical Center has been providing the community with compassionate, quality health care for more than 100 years. At the forefront of specialized care, research, and education, Long Beach Medical Center uses the most advanced healthcare technologies, including pioneering surgical systems like – ExactechGPS® and ExcelsiusGPS®. Recognized among the top 3% of all California acute care hospitals, Long Beach Medical Center is recognized as 'Best Hospital' for OBGYN and Orthopedics and ranked regionally in the Los Angeles Metro Area by U.S. News & World Report and earned Magnet® recognition for nursing excellence. With premier centers dedicated to cancer, heart, rehabilitation, orthopedics, neurosciences, and trauma, physicians and surrounding hospitals continually refer to its accredited programs. For more information, visit
Yahoo
04-06-2025
- Business
- Yahoo
MemorialCare Heart & Vascular Institute Completes First Successful TriClip Procedure for Tricuspid Valve Repair
LONG BEACH, Calif., June 4, 2025 /PRNewswire/ -- The cardiology team at the MemorialCare Heart & Vascular Institute at Long Beach Medical Center, led by Chief of Cardiology David Shavelle, M.D., performed Long Beach Medical Center's first transcatheter tricuspid valve replacement procedure using a new, innovative treatment option – the transcatheter edge-to edge repair (TEER) TriClip G4 System in September of 2024. The FDA-approved TriClip is a small clipping device designed to clip two or more of the leaflets of the tricuspid, offering a minimally invasive treatment option to patients who have tricuspid regurgitation (TR) – a condition where the tricuspid valve does not close completely when the right ventricle contracts. This device – implanted via a catheter inserted in the vein of the leg – helps reduce tricuspid regurgitation and promotes an immediate improvement in blood flow and allows patients to benefit from a less traumatic procedure and a faster recovery. This advanced technology marks a new era for treating tricuspid valve disease since prior to its introduction, patients could only receive a device better suited for the mitral valve (MitraClip® device). The TriClip device was specifically made for the tricuspid valve. In a large clinical trial, the device was shown to reduce symptoms and hospitalization for heart failure for patients at high-risk for open-heart surgery. "This new procedure represents a significant advancement in our ability to treat high-risk patients with tricuspid valve heart disease," says Dr. Shavelle, who led the landmark procedure. "Historically there wasn't much we could do for those who still had symptoms after tricuspid regurgitation treatment and who were at high-risk for open heart surgery. This device gives patients access to improved quality of life." This procedure was performed by a highly skilled, diverse team of cardiologists, cardiac surgeons, cardiac anesthesiologists and advanced imaging specialists from the MemorialCare Heart & Vascular Institute at Long Beach Medical Center. Implantation of the TriClip with the TriClip G4 System is as effective as open-heart surgery, helping patients return to their daily lives in one to two days. "The patient recovered in the hospital for about two days, and he was able to return to his daily life the following day," says Dr. Shavelle. "It's amazing to see the positive impact this device has on our patients, allowing them to return to their daily lives with improved heart function and overall well-being." The patient who received this procedure, Anthony Williams, reported being fatigued constantly with excessive swelling of the legs (edema) before the procedure. Today, he is more energetic than ever and ready to take on each day. MemorialCare Heart & Vascular Institute at Long Beach Medical Center is the first institute in the region to use this device and continues to lead in cardiovascular innovations, bringing patients with the latest technology advancements. As one of the most high performing hospitals according to U.S. News, MemorialCare Long Beach Medical Center is a six-time five-star recipient recognized for its excellence in cardiac care by Healthgrades, and has recently received the American Heart Association's Get With The Guidelines® Heart Failure Gold Plus Quality Achievement Award, as well as the American Heart Association/American Stroke Association's Get With The Guidelines® Stroke Gold Plus Quality Achievement Award. With these achievements and offering a comprehensive range of services for patients with cardiac disorders, including rehabilitation programs, Long Beach Medical Center is a community hospital dedicated in providing expert and compassionate care on par with those found in academic settings. About MemorialCare Long Beach Medical Center: MemorialCare Long Beach Medical Center is a member of MemorialCare, a not-for-profit, integrated healthcare system. Long Beach Medical Center has been providing the community with compassionate, quality health care for more than 100 years. At the forefront of specialized care, research, and education, Long Beach Medical Center uses the most advanced healthcare technologies, including pioneering surgical systems like – ExactechGPS® and ExcelsiusGPS®. Recognized among the top 3% of all California acute care hospitals, Long Beach Medical Center is recognized as "Best Hospital" for OBGYN and Orthopedics and ranked regionally in the Los Angeles Metro Area by U.S. News & World Report and earned Magnet® recognition for nursing excellence. With premier centers dedicated to cancer, heart, rehabilitation, orthopedics, neurosciences, and trauma, physicians and surrounding hospitals continually refer to its accredited programs. For more information, visit View original content to download multimedia: SOURCE MemorialCare Long Beach Medical Center
